Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 6:13:919942.
doi: 10.3389/fendo.2022.919942. eCollection 2022.

Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions

Affiliations
Review

Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions

Sophie Templer. Front Endocrinol (Lausanne). .

Abstract

Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened to the holy grail of diabetes management. The first iterations of glucose-responsive insulin delivery were pioneered in the 1960s and 1970s, with the development of systems that used venous glucose measurements to dictate intravenous infusions of insulin and dextrose in order to maintain normoglycemia. Only recently have these bulky, bedside technologies progressed to miniaturized, wearable devices. These modern closed-loop systems use interstitial glucose sensing, subcutaneous insulin pumps, and increasingly sophisticated algorithms. As the number of commercially available hybrid closed-loop systems has grown, so too has the evidence supporting their efficacy. Future challenges in closed-loop technology include the development of fully closed-loop systems that do not require user input for meal announcements or carbohydrate counting. Another evolving avenue in research is the addition of glucagon to mitigate the risk of hypoglycemia and allow more aggressive insulin dosing.

Keywords: artificial pancreas; closed-loop systems; glycemic control; medical devices; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Early closed-loop technologies: (A) Components of the Biostator (reproduced from Fogt et al., 1978); (B) A mobile version of the Biostator (reproduced from Pfeiffer 1987) (10, 11).
Figure 2
Figure 2
The six categories of closed-loop systems as defined by the JDRF.
Figure 3
Figure 3
Commercially available and in-development hybrid closed-loop systems. (A) MiniMed 670G with Guardian Link 3 sensor/transmitter. (B) Omnipod Horizon with patch-pump. (C) CamAPS FX algorithm hosted on Android. (D) Tandem t:slim X2 pump paired with Dexcom G6 sensor. (E) Diabeloop DLBG1 algorithm with Kaleido patch-pump and Dexcom G6 sensor.
Figure 4
Figure 4
A timeline of selected studies of closed-loop systems. CLS = closed-loop system; HCLS = hybrid closed-loop system. References: Weinzimer et al., (24), Phillip et al., (42), Russell et al., (43), Thabit et al., (26), Bergenstal et al., (27), Stewart et al., (44), Kovatchev et al., (45), El-Khatib et al., (46), Brown et al., (47), Tauschmann et al., (48), Lal et al., (32).

References

    1. Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. . The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med (1993) 329:977–86. doi: 10.1056/NEJM199309303291401 - DOI - PubMed
    1. The DCCT Research Group . Epidemiology of Severe Hypoglycemia in the Diabetes Control and Complications Trial. Am J Med (1991) 90:450–59. doi: 10.1016/0002-9343(91)90605-W - DOI - PubMed
    1. Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. . State of Type 1 Diabetes Management and Outcomes From the T1D Exchange in 2016-2018. Diabetes Technol Ther (2019) 21:66–72. doi: 10.1089/dia.2018.0384 - DOI - PMC - PubMed
    1. Hovorka R. Closed-Loop Insulin Delivery: From Bench to Clinical Practice. Nat Rev Endocrinol (2011) 7:385–95. doi: 10.1038/nrendo.2011.32 - DOI - PubMed
    1. Kadish AH. Automation Control of Blood Sugar a Servomechanism for Glucose Monitoring and Control. Trans Am Soc Artif Intern Organs (1963) 9:363–67. - PubMed